Table of Contents
RETRACTED

This article has been retracted as it was found to contain a substantial amount of material from the following published article: “Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis” published in Clinical and Developmental Immunology, vol. 2011, Article ID 843763, 13 pages, 2011, DOI: 10.1155/2011/843763.

Journal of Allergy
Volume 2011 (2011), Article ID 785983, 9 pages
http://dx.doi.org/10.1155/2011/785983
Review Article

Immunopathology and Immunogenetics of Allergic Bronchopulmonary Aspergillosis

Departments of Pediatrics, Division of Allergy and Immunology, Saint Louis University, 1465 S. Grand Boulevard, St. Louis, MO 63104, USA

Received 3 May 2011; Accepted 14 July 2011

Academic Editor: Prescott Woodruff

Copyright © 2011 Alan P. Knutsen. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Hinson, A. Moon, and N. Plummer, “Broncho-pulmonary aspergillosis,” Thorax, vol. 7, pp. 317–333, 1952. View at Google Scholar
  2. R. Patterson and T. Golbert, “Hypersensitivity disease of the lung,” University of Michigan Medical Center Journal, vol. 34, no. 1, pp. 8–11, 1968. View at Google Scholar · View at Scopus
  3. R. G. Slavin, D. J. Stanczyk, A. J. Lonigro, and G. O. Broun Sr., “Allergic bronchopulmonary aspergillosis: a north American rarity,” The American Journal of Medicine, vol. 47, no. 2, pp. 306–313, 1969. View at Google Scholar · View at Scopus
  4. A. P. Knutsen, D. R. Mueller, A. D. Levine, B. Chouhan, P. S. Hutcheson, and R. G. Slavin, “Asp fI CD4+ T(H2)-like T-cell lines in allergic bronchopulmonary aspergillosis,” Journal of Allergy and Clinical Immunology, vol. 94, no. 2, pp. 215–221, 1994. View at Google Scholar
  5. P. A. Greenberger and R. Patterson, “Allergic bronchopulmonary aspergillosis and the evaluation of the patient with asthma,” Journal of Allergy and Clinical Immunology, vol. 81, no. 4, pp. 646–650, 1988. View at Google Scholar · View at Scopus
  6. P. Laufer, J. N. Fink, and W. T. Bruns, “Allergic bronchopulmonary aspergillosis in cystic fibrosis,” Journal of Allergy and Clinical Immunology, vol. 73, no. 1 I, pp. 44–48, 1984. View at Google Scholar
  7. P. A. Greenberger, “Allergic bronchopulmonary aspergillosis,” Journal of Allergy and Clinical Immunology, vol. 110, no. 5, pp. 685–692, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. P. A. Greenberger, T. P. Miller, M. Roberts, and L. L. Smith, “Allergic bronchopulmonary aspergillosis in patients with and without evidence of bronchiectasis,” Annals of Allergy, vol. 70, no. 4, pp. 333–338, 1993. View at Google Scholar · View at Scopus
  9. P. A. Greenberger, “Allergic bronchopulmonary aspergillosis,” in Allergy: Principles and Practice, N. F. Adkinson Jr., J. W. Yunginger, W. W. Busse, B. S. Bochner, S. T. Holgate, and F. E. R. Simons, Eds., pp. 1353–1371, Mosby, St. Louis, Mo, USA, 2003. View at Google Scholar
  10. R. Patterson, P. A. Greenberger, R. C. Radin, and M. Roberts, “Allergic bronchopulmonary aspergillosis: staging as an aid to management,” Annals of Internal Medicine, vol. 96, no. 3, pp. 286–291, 1982. View at Google Scholar · View at Scopus
  11. D. A. Stevens, R. B. Moss, V. P. Kurup et al., “Allergic bronchopulmonary aspergillosis in cystic fibrosis—state of the art: cystic fibrosis foundation consensus conference,” Clinical Infectious Diseases, vol. 37, supplement 3, pp. S225–S264, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. E. Brummer, A. Maqbool, and D. A. Stevens, “Protection of bronchoalveolar macrophages by granulocyte-macrophage colony-stimulating factor against dexamethasone suppression of fungicidal activity for Aspergillus fumigatus conidia,” Medical Mycology, vol. 39, no. 6, pp. 509–515, 2001. View at Google Scholar
  13. S. Hemmann, W. H. Nikolaizik, M. H. Schoni, K. Blaser, and R. Crameri, “Differential IgE recognition of recombinant Aspergillus fumigatus allergens by cystic fibrosis patients with allergic bronchopulmonary aspergillosis or Aspergillus allergy,” European Journal of Immunology, vol. 28, no. 4, pp. 1155–1160, 1998. View at Google Scholar
  14. P. Latzin, D. Hartl, N. Regamey, U. Frey, M. H. Schoeni, and C. Casaulta, “Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis,” European Respiratory Journal, vol. 31, no. 1, pp. 36–42, 2008. View at Publisher · View at Google Scholar · View at PubMed
  15. D. Hartl, P. Latzin, G. Zissel, M. Krane, S. Krauss-Etschmann, and M. Griese, “Chemokines indicate allergic bronchopulmonary aspergillosis in patients with cystic fibrosis,” American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 12, pp. 1370–1376, 2006. View at Publisher · View at Google Scholar · View at PubMed
  16. R. G. Slavin, C. W. Bedrossian, P. S. Hutcheson et al., “A pathologic study of allergic bronchopulmonary aspergillosis,” Journal of Allergy and Clinical Immunology, vol. 81, no. 4, pp. 718–725, 1988. View at Google Scholar
  17. A. P. Knutsen, “Immunopathogenesis of allergic bronchopulmonary aspergillosis,” Frontiers in Bioscience, vol. 8, pp. 589–602, 2003. View at Google Scholar
  18. A. P. Knutsen, “Genetic risk factors in the development of allergic bronchopulmonary aspergillosis,” Current Trends in Immunology, vol. 7, pp. 47–54, 2006. View at Google Scholar
  19. A. P. Knutsen, B. Kariuki, L. Santiago et al., “HLA-DR, IL-4RA, and IL-10: genetic risk factors in allergic bronchopulmonary aspergillosis,” Pediatric Asthma, Allergy and Immunology, vol. 21, no. 4, pp. 185–190, 2009. View at Publisher · View at Google Scholar
  20. H. F. Kauffman, J. F. Christomee, M. A. van de Riet, A. J. Timmerman, and P. Borger, “Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production,” Journal of Allergy and Clinical Immunology, vol. 105, no. 6, pp. 1185–1193, 2000. View at Publisher · View at Google Scholar
  21. J. F. Tomee, H. F. Kauffman, A. H. Klimp, J. G. de Monchy, G. H. Köeter, and A. E. Dubois, “Immunologic significance of a collagen-derived culture filtrate containing proteolytic activity in Aspergillus-related diseases,” Journal of Allergy and Clinical Immunology, vol. 93, no. 4, pp. 768–778, 1994. View at Google Scholar
  22. A. Schaffner, H. Douglas, and A. Braude, “Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to aspergillus: observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes,” Journal of Clinical Investigation, vol. 69, no. 3, pp. 617–631, 1982. View at Google Scholar
  23. E. Roilides, K. Uhlig, D. Venzon, P. A. Pizzo, and T. J. Walsh, “Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon,” Infection and Immunity, vol. 61, no. 11, pp. 4870–4877, 1993. View at Google Scholar
  24. E. Brummer, A. Maqbool, and D. A. Stevens, “In vivo granulocyte macrophage colony-stimulating factor prevents dexamethasone suppression of killing of Aspergillus fumigatus by broncho-alveolar macrophages,” Journal of Leukocyte Biology, vol. 70, pp. 868–872, 2001. View at Google Scholar
  25. H. K. Kauffman and J. F. Tomee, “Inflammatory cells and airway defense against Aspergillus fumigatus,” Immunology and Allergy Clinics of North America, vol. 18, no. 3, pp. 619–640, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. J. F. Tomee and H. F. Kauffman, “Putative virulence factors of Aspergillus fumigatus,” Clinical and Experimental Allergy, vol. 30, no. 4, pp. 476–484, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. J. F. Tomee, A. T. J. Wierenga, P. S. Hiemstra, and H. F. Kauffman, “Proteases from Aspergillus fumigatus induce release of proinflammatory cytokines and cell detachment in airway epithelial cell lines,” Journal of Infectious Diseases, vol. 176, no. 1, pp. 300–303, 1997. View at Google Scholar · View at Scopus
  28. J. F. Tomee, T. S. van der Werf, J. P. Latge, G. H. Koeter, A. E. Dubois, and H. F. Kauffman, “Serologic monitoring of disease and treatment in a patient with pulmonary aspergilloma,” American Journal of Respiratory and Critical Care Medicine, vol. 151, no. 1, pp. 199–204, 1995. View at Google Scholar · View at Scopus
  29. L. Gu, S. Tseng, R. M. Horner, C. Tam, M. Loda, and B. J. Rollins, “Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1,” Nature, vol. 404, no. 6776, pp. 407–411, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. C. G. Persson, J. S. Erjefalt, I. Erjefalt, M. C. Kursgren, M. C. Nilsson, and F. Sundler, “Epithelial shedding-restitution as a causative process in airway inflammation,” Clinical and Experimental Allergy, vol. 26, no. 7, pp. 746–755, 1996. View at Google Scholar · View at Scopus
  31. A. P. Knutsen, B. Chauhan, and R. G. Slavin, “Cell-mediated immunity in allergic bronchopulmonary aspergillosis,” Immunology and Allergy Clinics of North America, vol. 18, no. 3, pp. 575–599, 1998. View at Publisher · View at Google Scholar · View at Scopus
  32. S. P. Khan, J. S. McClellan, and A. P. Knutsen, “Increased sensitivity to IL-4 in patients with allergic bronchopulmonary aspergillosis,” International Archives of Allergy and Immunology, vol. 123, no. 4, pp. 319–326, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. A. P. Knutsen, P. S. Hutchinson, G. M. Albers, J. Consolino, J. Smick, and V. P. Kurup, “Increased sensitivity to IL-4 in cystic fibrosis patients with allergic bronchopulmonary aspergillosis,” Allergy, vol. 59, no. 1, pp. 81–87, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. A. P. Knutsen, B. Kariuki, J. D. Consolino, and M. R. Warrier, “IL-4 alpha chain receptor (IL-4Rα) polymorphisms in allergic bronchopulmonary sspergillosis,” Clinical and Molecular Allergy, vol. 4, article 3, 2006. View at Publisher · View at Google Scholar · View at PubMed
  35. A. P. Knutsen, “Genetic and respiratory tract risk factors for aspergillosis: ABPA and asthma with fungal sensitization,” Medical Mycology, vol. 44, supplement 1, pp. S61–S70, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Crameri, S. Hemmann, C. Ismail, G. Menz, and K. Blaser, “Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis,” International Immunology, vol. 10, no. 8, pp. 1211–1216, 1998. View at Publisher · View at Google Scholar · View at Scopus
  37. H. J. Schwartz, K. M. Citron, E. H. Chester et al., “A comparison of the prevalence of sensitization to Aspergillus antigens among asthmatics in Cleveland and London,” Journal of Allergy and Clinical Immunology, vol. 62, no. 1, pp. 9–14, 1978. View at Google Scholar
  38. E. A. Valletta, C. Braggion, and G. Mastella, “Sensitization to Aspergillus and allergic bronchopulmonary Aspergillosis in a cystic fibrosis population,” Pediatric Asthma, Allergy and Immunology, vol. 7, no. 1, pp. 43–49, 1993. View at Google Scholar · View at Scopus
  39. A. P. Knutsen and R. G. Slavin, “In vitro T cell responses in patients with cystic fibrosis and allergic bronchopulmonary aspergillosis,” Journal of Laboratory and Clinical Medicine, vol. 113, no. 4, pp. 428–435, 1989. View at Google Scholar · View at Scopus
  40. R. G. Slavin, P. S. Hutcheson, and A. P. Knutsen, “Participation of cell-mediated immunity in allergic bronchopulmonary aspergillosis,” International Archives of Allergy and Applied Immunology, vol. 83, no. 4, pp. 337–340, 1987. View at Google Scholar · View at Scopus
  41. A. P. Knutsen, K. R. Mueller, P. S. Hutcheson, and R. G. Slavin, “T- and B-cell dysregulation of IgE synthesis in cystic fibrosis patients with allergic bronchopulmonary aspergillosis,” Clinical Immunology and Immunopathology, vol. 55, no. 1, pp. 129–138, 1990. View at Publisher · View at Google Scholar · View at Scopus
  42. B. A. Chauhan, A. P. Knutsen, P. S. Hutcheson, R. G. Slavin, and C. J. Bellone, “T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis,” Journal of Clinical Investigation, vol. 97, no. 10, pp. 2324–2331, 1996. View at Google Scholar · View at Scopus
  43. L. B. Bacharier and R. S. Geha, “Molecular mechanisms of IgE regulation,” Journal of Allergy and Clinical Immunology, vol. 105, supplement 2, pp. S547–S558, 2000. View at Google Scholar · View at Scopus
  44. V. P. Kurup, B. W. Seymour, H. Choi, and R. L. Coffman, “Particulate Aspergillus fumigatus antigens elicit a TH2 response in BALB/c mice,” Journal of Allergy and Clinical Immunology, vol. 93, no. 6, pp. 1013–1020, 1994. View at Publisher · View at Google Scholar · View at Scopus
  45. R. P. Schleimer, S. A. Sterbinsky, C. A. Kaiser et al., “IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium: association with expression of VCAM-1,” Journal of Immunology, vol. 148, no. 4, pp. 1086–1092, 1992. View at Google Scholar · View at Scopus
  46. R. Moser, J. Fehr, and P. L. Bruijnzeel, “IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals,” Journal of Immunology, vol. 149, no. 4, pp. 1432–1438, 1992. View at Google Scholar · View at Scopus
  47. J. Y. Bonnefoy, J. F. Gauchat, P. Life, P. Graber, J. P. Aubry, and S. Lecoanet-Henchoz, “Regulation of IgE synthesis by CD23/CD21 interaction,” International Archives of Allergy and Immunology, vol. 107, no. 1–3, pp. 40–42, 1995. View at Google Scholar · View at Scopus
  48. J. Y. Bonnefoy, J. F. Gauchat, P. Life, P. Graber, G. Mazzei, and J. P. Aubry, “Pairs of surface molecules involved in human IgE regulation: CD23-CD21 and CD40-CD40L,” European Respiratory Journal, Supplement, vol. 9, supplement 22, pp. 63S–66S, 1996. View at Google Scholar
  49. L. J. Rosenwasser, W. W. Busse, R. G. Lizambri, T. A. Olejnik, and M. C. Totoritis, “Allergic asthma and an anti-CD23 mAb (IDEC-152): results of a phase I, single-dose, dose-escalating clinical trial,” Journal of Allergy and Clinical Immunology, vol. 112, no. 3, pp. 563–570, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. D. Vercelli, H. H. Jabara, K. I. Arai, and R. S. Geha, “Induction of human IgE synthesis requires interleukin 4 and T/B cell interactions involving the T cell receptor/CD3 complex and MHC class II antigens,” Journal of Experimental Medicine, vol. 169, no. 4, pp. 1295–1307, 1989. View at Google Scholar · View at Scopus
  51. J. Punnonen, G. Aversa, B. G. Cocks et al., “Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 8, pp. 3730–3734, 1993. View at Google Scholar · View at Scopus
  52. T. Defrance, P. Carayon, G. Billian et al., “Interleukin 13 is a B cell stimulating factor,” Journal of Experimental Medicine, vol. 179, no. 1, pp. 135–143, 1994. View at Publisher · View at Google Scholar · View at Scopus
  53. B. Chauhan, L. Santiago, D. A. Kirschmann et al., “The association of HLA-DR alleles and T cell activation with allergic bronchopulmonary aspergillosis,” Journal of Immunology, vol. 159, no. 8, pp. 4072–4076, 1997. View at Google Scholar · View at Scopus
  54. J. R. Lamb, J. A. Higgins, C. Hetzel, J. D. Hayball, R. A. Lake, and R. E. O'Hehir, “The effects of changes at peptide residues contacting MHC class II T-cell receptor on antigen recognition and human Th0 cell effector function,” Immunology, vol. 85, no. 3, pp. 447–454, 1995. View at Google Scholar
  55. D. C. Tsitoura, A. Verhoef, C. M. Gelder, R. E. O'Hehir, and J. R. Lamb, “Altered T cell ligands derived from a major house dust mite allergen enhance IFN-γ but not IL-4 production by human CD4+ T cells,” Journal of Immunology, vol. 157, no. 5, pp. 2160–2165, 1996. View at Google Scholar
  56. C. Pfeiffer, J. Stein, S. Southwood, H. Ketelaar, A. Sette, and K. Bottomly, “Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo,” Journal of Experimental Medicine, vol. 181, no. 4, pp. 1569–1574, 1995. View at Publisher · View at Google Scholar
  57. B. D. Evavold, J. Sloan-Lancaster, B. L. Hsu, and P. M. Allen, “Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides,” Journal of Immunology, vol. 150, no. 8, pp. 3131–3140, 1993. View at Google Scholar
  58. L. Racioppi, F. Ronchese, L. A. Matis, and R. N. Germain, “Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling,” Journal of Experimental Medicine, vol. 177, no. 4, pp. 1047–1060, 1993. View at Google Scholar
  59. K. Nelms, A. D. Keegan, J. Zamorano, J. J. Ryan, and W. E. Paul, “The IL-4 receptor: signaling mechanisms and biologic functions,” Annual Review of Immunology, vol. 17, pp. 701–738, 1999. View at Publisher · View at Google Scholar · View at PubMed
  60. T. Habib, A. Nelson, and K. Kaushansky, “IL-21: a novel IL-2-family lymphokine that modulates B, T, and natural killer cell responses,” Journal of Allergy and Clinical Immunology, vol. 112, no. 6, pp. 1033–1045, 2003. View at Publisher · View at Google Scholar · View at PubMed
  61. G. K. Khurana Hershey, “IL-13 receptors and signaling pathways: an evolving web,” Journal of Allergy and Clinical Immunology, vol. 111, no. 4, pp. 677–690, 2003. View at Publisher · View at Google Scholar
  62. G. K. Hershey, M. F. Friedrich, L. A. Esswein, M. L. Thomas, and T. A. Chatila, “The association of atopy with a gain-of-function mutation in the α subunit of the interleukin-4 receptor,” New England Journal of Medicine, vol. 337, no. 24, pp. 1720–1725, 1997. View at Publisher · View at Google Scholar · View at PubMed
  63. K. Deichmann, J. Bardutzky, J. Forster, A. Heinzmann, and J. Kuehr, “Common polymorphisms in the coding part of the IL4-Receptor gene,” Biochemical and Biophysical Research Communications, vol. 231, no. 3, pp. 696–697, 1997. View at Publisher · View at Google Scholar · View at PubMed
  64. S. Kruse, T. Japha, M. Tedner et al., “The polymorphisms S503P and Q576R in the interleukin-4 receptor α gene are associated with atopy and influence the signal transduction,” Immunology, vol. 96, no. 3, pp. 365–371, 1999. View at Publisher · View at Google Scholar
  65. C. Ober, S. A. Leavitt, A. Tsalenko et al., “Variation in the interleukin 4-receptor α gene confers susceptibility to asthma and atopy in ethnically diverse populations,” American Journal of Human Genetics, vol. 66, no. 2, pp. 517–526, 2000. View at Publisher · View at Google Scholar · View at PubMed
  66. K. A. Deichmann, A. Heinzmann, J. Forster et al., “Linkage and allelic association of atopy and markers flanking the IL4- receptor gene,” Clinical and Experimental Allergy, vol. 28, no. 2, pp. 151–155, 1998. View at Publisher · View at Google Scholar
  67. H. Mitsuyasu, K. Izuhara, X. Q. Mao et al., “Ile50Val variant of IL4R alpha upregulates IgE synthesis and associates with atopic asthma,” Nature Genetics, vol. 19, no. 2, pp. 119–120, 1998. View at Google Scholar
  68. L. Rosa-Rosa, N. Zimmermann, J. A. Bernstein, M. E. Rothenberg, and G. K. Khurana Hershey, “The R576 IL-4 receptor allele correlates with asthma severity,” Journal of Allergy and Clinical Immunology, vol. 104, no. 5, pp. 1008–1014, 1999. View at Publisher · View at Google Scholar
  69. E. Noguchi, M. Shibasaki, T. Arinami et al., “No association between atopy/asthma and the Ile50Val polymorphism of IL- 4 receptor,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 1, pp. 342–345, 1999. View at Google Scholar
  70. H. Mitsuyasu, Y. Yanagihara, X. Q. Mao et al., “Cutting edge: dominant effect of Ile50Val variant of the human IL-4 receptor α-chain in IgE synthesis,” Journal of Immunology, vol. 162, no. 3, pp. 1227–1231, 1999. View at Google Scholar
  71. K. A. Risma, N. Wang, R. P. Andrews et al., “V75R576 IL-4 receptor α is associated with allergic asthma and enhanced IL-4 receptor function,” Journal of Immunology, vol. 169, no. 3, pp. 1604–1610, 2002. View at Google Scholar
  72. J. Brourad, N. Knauer, P. Y. Boelle et al., “Influence of interleukin-10 on airways colonization by Aspergillus fumigatus in cystic fibrosis patients,” Journal of Infectious Diseases, vol. 191, pp. 1988–1991, 2005. View at Google Scholar
  73. S. Saxena, T. Madan, A. Shah, K. Muralidhar, and P. A. Sarma, “Association of polymorphisms in the collagen region of SP-A2 with increased levels of total IgE antibodies and eosinophilia in patients with allergic bronchopulmonary aspergillosis,” Journal of Allergy and Clinical Immunology, vol. 111, no. 5, pp. 1001–1007, 2003. View at Publisher · View at Google Scholar
  74. L. F. Weikert, K. Edwards, Z. C. Chroneos et al., “SP-A enhances uptake of bacillus Calmette-Guerin by macrophages through a specific SP-A receptor,” American Journal of Physiology, vol. 272, no. 5, pp. L989–L995, 1997. View at Google Scholar
  75. P. W. Miller, A. Hamosh, M. Macek Jr. et al., “Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis,” American Journal of Human Genetics, vol. 59, no. 1, pp. 45–51, 1996. View at Google Scholar
  76. A. Carvalho, A. C. Pasqualotto, L. Pitzurra, L. Romani, D. W. Denning, and F. Rodrigues, “Polymorphisms in toll-like receptor genes and susceptibility to pulmonary aspergillosis,” Journal of Infectious Diseases, vol. 197, no. 4, pp. 618–621, 2008. View at Publisher · View at Google Scholar · View at PubMed
  77. J. E. Wang, A. Warris, E. A. Ellingsen et al., “Involvement of CD14 and toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae,” Infection and Immunity, vol. 69, no. 4, pp. 2402–2406, 2001. View at Publisher · View at Google Scholar · View at PubMed
  78. S. Bellocchio, S. Moretti, K. Perruccio et al., “TLRs govern neutrophil activity in aspergillosis,” Journal of Immunology, vol. 173, no. 12, pp. 7406–7415, 2004. View at Google Scholar
  79. R. Lazarus, W. T. Klimecki, B. A. Raby et al., “Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case-control disease association studies,” Genomics, vol. 81, no. 1, pp. 85–91, 2003. View at Publisher · View at Google Scholar
  80. N. Novak, C. F. Yu, C. Bussmann et al., “Putative association of a TLR9 promoter polymorphism with atopic eczema,” Allergy, vol. 62, no. 7, pp. 766–772, 2007. View at Publisher · View at Google Scholar · View at PubMed